|
|
Volumn 67, Issue 5, 2009, Pages 494-502
|
|
Orphan drug development is not taking off: Commentary
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGALSIDASE ALFA;
AGALSIDASE BETA;
AMINOLEVULINIC ACID;
ANAGRELIDE;
ARSENIC TRIOXIDE;
BETAINE;
BOSENTAN;
BUSULFAN;
CARGLUMIC ACID;
CELECOXIB;
CLADRIBINE;
CLOFARABINE;
DASATINIB;
DEFERASIROX;
ECULIZUMAB;
GALSULFASE;
HYDROXYUREA;
IBUPROFEN;
IDURONATE 2 SULFATASE;
ILOPROST;
IMATINIB;
LARONIDASE;
LENALIDOMIDE;
LITAK;
MIGLUSTAT;
MITOTANE;
NELARABINE;
NILOTINIB;
NITISINONE;
OMEGA CONOTOXIN MVIIA;
ORPHAN DRUG;
OXYBATE SODIUM;
PEGVISOMANT;
PHOTOFRIN;
RAZOXANE;
RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;
RECOMBINANT SOMATOMEDIN C;
RUFINAMIDE;
SIKLOS;
SILDENAFIL;
SITAXSENTAN;
SORAFENIB;
STIRIPENTOL;
SUNITINIB;
TEMSIROLIMUS;
TRABECTEDIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WILZIN;
ACUTE CHEST SYNDROME;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADENOMATOUS POLYP;
ADRENAL CORTEX CARCINOMA;
CANCER SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
DRUG APPROVAL;
DRUG EFFICACY;
ENZYME DEFICIENCY;
EUROPE;
EXTRAVASATION;
FABRY DISEASE;
GASTROINTESTINAL STROMAL TUMOR;
GAUCHER DISEASE;
GLYCOGEN STORAGE DISEASE TYPE 2;
HEMOSIDEROSIS;
HUMAN;
HUNTER SYNDROME;
HURLER SYNDROME;
INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY;
LEUKEMIA;
MEDICINAL PLANT;
MULTIPLE MYELOMA;
NONHUMAN;
NOTE;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
PATENT DUCTUS ARTERIOSUS;
PREVALENCE;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
PROTEIN DEFICIENCY;
PUBLIC HEALTH;
PULMONARY HYPERTENSION;
QUALITY OF LIFE;
THROMBOCYTHEMIA;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
HUMANS;
ORPHAN DRUG PRODUCTION;
PHARMACEUTICAL PREPARATIONS;
|
|
EID: 65349108095
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.2009.03369.x Document Type: Note |
|
Times cited : (57)
|
|
References (9)
|
